226 related articles for article (PubMed ID: 22928581)
1. Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays.
Vande Casteele N; Buurman DJ; Sturkenboom MG; Kleibeuker JH; Vermeire S; Rispens T; van der Kleij D; Gils A; Dijkstra G
Aliment Pharmacol Ther; 2012 Oct; 36(8):765-71. PubMed ID: 22928581
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum.
Wang SL; Ohrmund L; Hauenstein S; Salbato J; Reddy R; Monk P; Lockton S; Ling N; Singh S
J Immunol Methods; 2012 Aug; 382(1-2):177-88. PubMed ID: 22691619
[TBL] [Abstract][Full Text] [Related]
3. The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful.
Ben-Horin S; Yavzori M; Katz L; Kopylov U; Picard O; Fudim E; Coscas D; Bar-Meir S; Goldstein I; Chowers Y
Gut; 2011 Jan; 60(1):41-8. PubMed ID: 20519742
[TBL] [Abstract][Full Text] [Related]
4. Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease.
Imaeda H; Andoh A; Fujiyama Y
J Gastroenterol; 2012 Feb; 47(2):136-43. PubMed ID: 21953314
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.
Marini JC; Sendecki J; Cornillie F; Popp JW; Black S; Blank M; Gils A; Van Stappen T; Hamann D; Rispens T; Thérien L; Chun K; Shankar G
AAPS J; 2017 Jan; 19(1):161-171. PubMed ID: 27600137
[TBL] [Abstract][Full Text] [Related]
6. The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab.
Ungar B; Chowers Y; Yavzori M; Picard O; Fudim E; Har-Noy O; Kopylov U; Eliakim R; Ben-Horin S;
Gut; 2014 Aug; 63(8):1258-64. PubMed ID: 24041539
[TBL] [Abstract][Full Text] [Related]
7. Significance of low level infliximab in the absence of anti-infliximab antibodies.
Ungar B; Anafy A; Yanai H; Ron Y; Yavzori M; Picard O; Fudim E; Loebstein R; Kopylov U; Chowers Y; Dotan I; Eliakim R; Ben-Horin S
World J Gastroenterol; 2015 Feb; 21(6):1907-14. PubMed ID: 25684959
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
Nasser Y; Labetoulle R; Harzallah I; Berger AE; Roblin X; Paul S
Dig Dis Sci; 2018 Oct; 63(10):2714-2721. PubMed ID: 29948562
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to infliximab and its impact on pharmacokinetics can be transient.
Vande Casteele N; Gils A; Singh S; Ohrmund L; Hauenstein S; Rutgeerts P; Vermeire S
Am J Gastroenterol; 2013 Jun; 108(6):962-71. PubMed ID: 23419382
[TBL] [Abstract][Full Text] [Related]
10. Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab.
Plasencia C; Pascual-Salcedo D; Nuño L; Bonilla G; Villalba A; Peiteado D; Díez J; Nagore D; del Agua AR; Moral R; Martin-Mola E; Balsa A
Ann Rheum Dis; 2012 Dec; 71(12):1955-60. PubMed ID: 22563028
[TBL] [Abstract][Full Text] [Related]
11. An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases.
Van Stappen T; Billiet T; Vande Casteele N; Compernolle G; Brouwers E; Vermeire S; Gils A
Inflamm Bowel Dis; 2015 Sep; 21(9):2172-7. PubMed ID: 26284296
[TBL] [Abstract][Full Text] [Related]
12. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial.
Farrell RJ; Alsahli M; Jeen YT; Falchuk KR; Peppercorn MA; Michetti P
Gastroenterology; 2003 Apr; 124(4):917-24. PubMed ID: 12671888
[TBL] [Abstract][Full Text] [Related]
13. Anti-infliximab antibody status and its relation to clinical response in psoriatic patients: A pilot study.
Adişen E; Aral A; Aybay C; Gürer MA
J Dermatol; 2010 Aug; 37(8):708-13. PubMed ID: 20649712
[TBL] [Abstract][Full Text] [Related]
14. Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays.
Parussini E
Aliment Pharmacol Ther; 2013 Jan; 37(2):281. PubMed ID: 23252782
[No Abstract] [Full Text] [Related]
15. Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' reply.
Buurman DJ; Vande Casteele N; Sturkenboom MG; Kleibeuker JH; Vermeire S; van der Kleij D; Rispens T; Gils A; Dijkstra G
Aliment Pharmacol Ther; 2013 Jan; 37(2):282. PubMed ID: 23252783
[No Abstract] [Full Text] [Related]
16. Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational Study.
Berger AE; Duru G; de Vries A; Marini JC; Aoucheta D; Cornillie F; Nancey S; Detrez I; Gils A; Roblin X; Paul S
Ther Drug Monit; 2019 Aug; 41(4):459-466. PubMed ID: 30817702
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three commercially available ELISA assays for anti-infliximab antibodies.
West TA; Sam M; Toong C
Pathology; 2021 Jun; 53(4):508-514. PubMed ID: 33272693
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies.
Kopylov U; Mazor Y; Yavzori M; Fudim E; Katz L; Coscas D; Picard O; Chowers Y; Eliakim R; Ben-Horin S
Inflamm Bowel Dis; 2012 Sep; 18(9):1628-33. PubMed ID: 22038899
[TBL] [Abstract][Full Text] [Related]
19. Comparison of infliximab drug measurement across three commercially available ELISA kits.
Lee MW; Connor S; Ng W; Toong CM
Pathology; 2016 Oct; 48(6):608-12. PubMed ID: 27567230
[TBL] [Abstract][Full Text] [Related]
20. Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failure.
Ungar B; Haj-Natour O; Kopylov U; Yavzori M; Fudim E; Picard O; Loebstein R; Lahat A; Maor Y; Avidan B; Lang A; Weiss B; Chowers Y; Eliakim R; Ben-Horin S
Medicine (Baltimore); 2015 May; 94(18):e673. PubMed ID: 25950682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]